Hongzheng Li

机构：University of British Columbia, Chinese Academy of Medical Sciences & Peking Union Medical College, Wuhan University, Wuhan Institute of Virology, National Clinical Research, Second Hospital of Tianjin Medical University, China Academy of Chinese Medical Sciences, Guang’anmen Hospital, Tianjin Medical University · ORCID：0000-0002-3459-9539

发表论文 27 篇 · 总被引 58 次 · h-index 3

代表论文

• Quantitative visualization of myocardial ischemia-reperfusion-induced cardiac lesions via ferroptosis magnetic particle imaging (2024 · Theranostics · 被引 21)
• Dehydrocorydaline attenuates myocardial ischemia-reperfusion injury via the FoXO signalling pathway: A multimodal study based on network pharmacology, molecular docking, and experimental study (2024 · Journal of Ethnopharmacology · 被引 14)
• Effects and mechanism of Kedaling tablets for atherosclerosis treatment based on network pharmacology, molecular docking and experimental study (2023 · Journal of Ethnopharmacology · 被引 13)
• Integrative analysis of serum lipids and chronic gastritis: causal insights from mendelian randomization and experimental models (2025 · Lipids in Health and Disease · 被引 3)
• Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma (2025 · BMC Cancer · 被引 3)
• Research on postoperative complications following transcatheter aortic valve replacement: a bibliometric and visual analysis from 2006 to 2025 (2026 · Acta cardiologica. Supplementum · 被引 2)